T01-P-025 Rosiglitazone lowers apolipoprotein A1 and apolipoprotein B levels and increases LDL/APOB ratio in patients with type 2 diabetes and hypertension

Saved in:
Bibliographic Details
Published in:Atherosclerosis. Supplements 2005-04, Vol.6 (1), p.139-139
Main Authors: Sarafidis, P., Lasaridis, A., Yovos, J., Mousleh, T., Kazakos, K., Makedou-HitogIou, A., Pliakos, C., Stafilas, P., Tourkantonis, A., Nilsson, P.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1567-5688
1878-5050
DOI:10.1016/S1567-5688(05)80542-2